References
- Aberle, D. R., DeMello, S., Berg, C. D., Black, W. C., Brewer, B., Church, T. R., Clingan, K. L., Duan, F., Fagerstrom, R. M., Gareen, I. F., Gatsonis, C. A., Gierada, D. S., Jain, A., Jones, G. C., Mahon, I., Marcus, P. M., Rathmell, J. M., Sicks, J., & National Lung Screening Trial Research Team. (2013). Results of the two incidence screenings in the national lung screening trial. New England Journal of Medicine, 369(10), 920–931. https://doi.org/10.1056/NEJMoa1208962
- Brock, M. V., Hooker, C. M., Engels, E. A., Moore, R. D., Gillison, M. L., Alberg, A. J., Keruly, J. C., Yang, S. C., Heitmiller, R. F., Baylin, S. B., Herman, J. G., & Brahmer, J. R. (2006). Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: Implications for patient care. JAIDS Journal of Acquired Immune Deficiency Syndromes, 43(1), 47–55. https://doi.org/10.1097/01.qai.0000232260.95288.93
- Canadian Cancer Society. (2019). Canadian Cancer Statistics 2019. Retrieved April 13, 2020, from www.cancer.ca>Canadian-Cancer-Statistics-2019-EN
- Cioaia, S., Tornero, C., Sanchez, E., & Alos, M. (2019). Care burden derived from the introduction of an early lung cancer screening program in high-risk HIV-infected patients. Journal of the International Association of Providers of AIDS Care (JIAPAC), 18. https://doi.org/10.1177/2325958219839077
- Coghill, A. E., Han, X., Suneja, G., Lin, C. C., Jemal, A., & Shiels, M. S. (2019). Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the national cancer data base. Cancer. https://doi.org/10.1002/cncr.32158
- Costiniuk, C. T., Salahuddin, S., Farnos, O., Olivenstein, R., Pagliuzza, A., Orlova, M., Schurr, E., De Castro, C., Bourbeau, J., Routy, J. P., Ancuta, P., Chomont, N., & Jenabian, M. A. (2018). HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy. AIDS, 32(16), 2279–2289. https://doi.org/10.1097/QAD.0000000000001962
- Engels, E. A., Pfeiffer, R. M., Goedert, J. J., Virgo, P., McNeel, T. S., Scoppa, S. M., & Biggar, R. J. (2006). Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS, 20(12), 1645–1654. https://doi.org/10.1097/01.aids.0000238411.75324.59
- Guiguet, M., Boue, F., Cadranel, J., Lang, J. M., Rosenthal, E., Costagliola, D., & Clinical Epidemiology Group of the FHDH-ANRS CO4 Cohort. (2009). Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. The Lancet Oncology, 10(12), 1152–1159. https://doi.org/10.1016/S1470-2045(09)70282-7
- Hakimian, R., Fang, H., Thomas, L., & Edelman, M. J. (2007). Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy. Journal of Thoracic Oncology, 2(4), 268–272. https://doi.org/10.1097/01.JTO.0000263707.31202.d7
- Howlader, N., Ries, L. A., Mariotto, A. B., Reichman, M. E., Ruhl, J., & Cronin, K. A. (2010). Improved estimates of cancer-specific survival rates from population-based data. JNCI: Journal of the National Cancer Institute, 102(20), 1584–1598. https://doi.org/10.1093/jnci/djq366
- Kong, C. Y., Sigel, K., Criss, S. D., Sheehan, D. F., Triplette, M., Silverberg, M. J., Henschke, C. I., Justice, A., Braithwaite, R. S., Wisnivesky, J., & Crothers, K. (2018). Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/mul. AIDS, 32(10), 1333–1342. https://doi.org/10.1097/QAD.0000000000001818
- Makinson, A., Eymard-Duvernay, S., Raffi, F., Abgrall, S., Bommart, S., Zucman, D., Valour, F., Cheret, A., Poizot-Martin, I., Duvivier, C., Mauboussin, J. M., Bonnet, F., Tattevin, P., Reynes, J., & Le Moing, V. (2016). Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers. Aids, 30(4), 573–582. https://doi.org/10.1097/QAD.0000000000000943
- Makinson, A., Le Moing, V., Reynes, J., Ferry, T., Lavole, A., Poizot-Martin, I., & Milleron, B. (2016). Lung cancer screening with chest computed tomography in people living with HIV: A review by the multidisciplinary CANCERVIH Working Group. Journal of Thoracic Oncology, 11(10), 1644–1652. https://doi.org/10.1016/j.jtho.2016.06.026
- Molto, J., Moran, T., Sirera, G., & Clotet, B. (2015). Lung cancer in HIV-infected patients in the combination antiretroviral treatment era. Translational Lung Cancer Research, 4(6), 678–688. https://doi.org/10.3978/j.issn.2218-6751.2015.08.10
- National Lung Screening Trial Research Team, Aberle, D. R., Adams, A. M., Berg, C. D., Black, W. C., Clapp, J. D., Fagerstrom, R. M., Gareen, I. F., Gatsonis, C., Marcus, P. M., & Sicks, J. D. (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal of Medicine, 365(5), 395–409. https://doi.org/10.1056/NEJMoa1102873
- Persad, G. C., Little, R. F., & Grady, C. (2008). Including persons with HIV infection in cancer clinical trials. Journal of Clinical Oncology, 26(7), 1027–1032. https://doi.org/10.1200/JCO.2007.14.5532
- Sigel, K., Pitts, R., & Crothers, K. (2016). Lung malignancies in HIV infection. Seminars in Respiratory and Critical Care Medicine, 37(2), 267–276. https://doi.org/10.1055/s-0036-1578803
- Suneja, G., Boyer, M., Yehia, B. R., Shiels, M. S., Engels, E. A., Bekelman, J. E., & Long, J. A. (2015). Cancer treatment in patients with HIV infection and non-AIDS-defining cancers: A survey of US oncologists. Journal of Oncology Practice, 11(3), e380–e387. https://doi.org/10.1200/JOP.2014.002709
- Tirelli, U., Spina, M., Sandri, S., Serraino, D., Gobitti, C., Fasan, M., & Vaccher, E. (2000). Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and tumors. Cancer, 88(3), 563–569. https://doi.org/10.1002/(sici)1097-0142(20000201)88:3<563::aid-cncr11>3.0.co;2-d
- Triplette, M., Sigel, K. M., Morris, A., Shahrir, S., Wisnivesky, J. P., Kong, C. Y., & Crothers, K. (2017). Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: Implications for lung cancer screening. AIDS, 31(12), 1715–1720. https://doi.org/10.1097/QAD.0000000000001529
- Twigg, H. L., Soliman, D. M., Day, R. B., Knox, K. S., Anderson, R. J., Wilkes, D. S., & Schnizlein-Bick, C. T. (1999). Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. American Journal of Respiratory and Critical Care Medicine, 159(5 Pt 1), 1439–1444. https://doi.org/10.1164/ajrccm.159.5.9808031
- Winstone, T. A., Man, S. F. P., Hull, M., Montaner, J. S., & Sin, D. D. (2013). Epidemic of lung cancer in patients with HIV infection. Chest, 143(2), 305–314. https://doi.org/10.1378/chest.12-1699
- Worm, S. W., Bower, M., Reiss, P., Bonnet, F., Law, M., Fatkenheuer, G., Fätkenheuer, G., d’Arminio Monforte, A., Abrams, D. I., Grulich, A., Fontas, E., Kirk, O., Furrer, H., De Wit, S., Phillips, A., Lundgren, J. D., Sabin, C. A., & for the D:A:D Study Group. (2013). Non-AIDS defining cancers in the D:A:D study–time trends and predictors of survival: A cohort study. BMC Infectious Diseases, 13, 471. https://doi.org/10.1186/1471-2334-13-471